Search research articles
Contact Us
Filters
Showing results (71-80 of 616) with videos related to
Page
of 62
Sort By:
Digestive Diseases and Sciences
|
June 15, 2015
The Polymerase Chain Reaction: Essential for the Development of Curative Therapy for Hepatitis C
Eoin R Feeney, Raymond T Chung
The AIDS Reader
|
June 27, 2006
Management of hepatitis C virus coinfection in HIV-infected persons
Jacqueline G O'Leary, Raymond T Chung
Gastroenterology
|
April 10, 2007
Vaccine-induced T-cell responses against HCV: one step taken, more to follow
Georg M Lauer, Raymond T Chung
Hepatology (Baltimore, Md.)
|
April 29, 2009
Monitoring during and after antiviral therapy for hepatitis B
Karin L Andersson, Raymond T Chung
Gastroenterology
|
June 25, 2009
Coinfection with HIV-1 and HCV--a one-two punch
Arthur Y Kim, Raymond T Chung
JAMA
|
December 17, 2014
Optimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma
Jeremy S Abramson, Raymond T Chung
The Lancet. Gastroenterology & Hepatology
|
June 20, 2020
Shortening treatment with direct-acting antivirals in HCV-positive organ transplantation
Jacinta A Holmes, Raymond T Chung
JHEP Reports : Innovation in Hepatology
|
December 24, 2024
The future of clinical trials of gut microbiome therapeutics in cirrhosis
Patricia P Bloom, Raymond T Chung
Hepatology (Baltimore, Md.)
|
December 4, 2009
Tumorigenicity of human induced pluripotent stem cells depends on the balance of gene expression between p21 and p53
Hisashi Moriguchi, Raymond T Chung, Chifumi Sato
Gastroenterology
|
May 17, 2008
Broadly neutralizing antibodies against hepatitis C virus: new hope for immunization?
Barham K Abu Dayyeh, Raymond T Chung
Page
of 62
Search research articles
Search
Showing results (71-80 of 616) with videos related to
Sort By:
Page
of 62
Digestive Diseases and Sciences
|
June 15, 2015
The Polymerase Chain Reaction: Essential for the Development of Curative Therapy for Hepatitis C
Eoin R Feeney, Raymond T Chung
The AIDS Reader
|
June 27, 2006
Management of hepatitis C virus coinfection in HIV-infected persons
Jacqueline G O'Leary, Raymond T Chung
Gastroenterology
|
April 10, 2007
Vaccine-induced T-cell responses against HCV: one step taken, more to follow
Georg M Lauer, Raymond T Chung
Hepatology (Baltimore, Md.)
|
April 29, 2009
Monitoring during and after antiviral therapy for hepatitis B
Karin L Andersson, Raymond T Chung
Gastroenterology
|
June 25, 2009
Coinfection with HIV-1 and HCV--a one-two punch
Arthur Y Kim, Raymond T Chung
JAMA
|
December 17, 2014
Optimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma
Jeremy S Abramson, Raymond T Chung
The Lancet. Gastroenterology & Hepatology
|
June 20, 2020
Shortening treatment with direct-acting antivirals in HCV-positive organ transplantation
Jacinta A Holmes, Raymond T Chung
JHEP Reports : Innovation in Hepatology
|
December 24, 2024
The future of clinical trials of gut microbiome therapeutics in cirrhosis
Patricia P Bloom, Raymond T Chung
Hepatology (Baltimore, Md.)
|
December 4, 2009
Tumorigenicity of human induced pluripotent stem cells depends on the balance of gene expression between p21 and p53
Hisashi Moriguchi, Raymond T Chung, Chifumi Sato
Gastroenterology
|
May 17, 2008
Broadly neutralizing antibodies against hepatitis C virus: new hope for immunization?
Barham K Abu Dayyeh, Raymond T Chung
Page
of 62